Live Breaking News & Updates on Chief Biomedical Scientist

Stay updated with breaking news from Chief biomedical scientist. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

An evening of laughter with Dave Spikey at The Mart Theatre

COMING up in January at The Mart Theatre, Skipton is the hilarious Dave Spikey for an evening of laughter. ....

Dave Spikey , Pathology Department , Bolton General Hospital , Chief Biomedical Scientist , Smart Theatre ,

Schrodinger Inc (SDGR) Q1 2021 Earnings Call Transcript


Operator
Thank you for standing by. Welcome to Schrodinger s conference call to review the company s first quarter financial results. My name is Kevin, and I ll be your operator for today s call.
[Operator Instructions]
Now, I would like to introduce your host for today s conference call, Jaren Madden, Senior Vice President of Investor Relations and Corporate Communications. Please go ahead.
Jaren Madden
Senior Vice President, Investor Relations and Corporate Communications
Thank you, and hello, everyone. Welcome to today s call during which we will provide an update on the company and review our financial results for the first quarter of 2021. Earlier this morning, we issued a press release summarizing our financial results and progress across the company, which is available on our website at www.schrodinger.com. Here with me on our call today are Ramy Farid, President and Chief Executive Officer; Karen Akinsanya, Executive Vice President, Chief Biomedi ....

United States , Joel Lebowitz , Karen Akinsanya , Michael Ryskin , Jaren Madden , Michael Yee Jefferies , Ramy Farid , Michael Yee , Schrodinger Inc , American Society Of Hematology , Exchange Commission , Corporate Communications , Bristol Myers Squibb , Michael Ryskin Bank , Senior Vice President , Investor Relations , Vice President , Chief Executive Officer , Executive Vice President , Chief Biomedical Scientist , Chief Financial , Safe Harbor , Private Securities Litigation Reform Act , Risk Factors , Chief Executive , Morphic Therapeutic ,

Schrodinger Inc (SDGR) Q4 2020 Earnings Call Transcript


Operator
Thank you for standing by, and welcome to Schrodinger s Conference Call for the Fourth quarter and Full Year 2020 Financial Results. My name is Sarah, and I ll be your conference operator today. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions]
Now, I d like to introduce your host for today s conference, Ms. Irene Madden, Senior Vice President of Investor Relations and Communications. Please go ahead.
Jaren Madden
Senior Vice President of Investor Relations and Communications
Thank you, and good morning, everyone. Welcome to today s call during which we will provide an update on the company and review our fourth quarter and full year 2020 financial results. Earlier this morning, we issued a press release summarizing our financial results and progress across the company, which is available on our website at www.schrodinger.com. Here with me on our call today is Ramy Farid, President and Chief Execu ....

United States , Joel Lebowitz , Karen Akinsanya , Ramy Farid , Michael Yee , Irene Madden , Bristol Myers Squibb , Exchange Commission , American Society For Hematology Annual Meeting , Schrodinger Inc , Head Of Early Development , Conference Call , Full Year , Senior Vice President , Investor Relations , Vice President , Chief Executive Officer , Executive Vice President , Chief Biomedical Scientist , Chief Financial , Safe Harbor , Private Securities Litigation Reform Act , Risk Factors , Chief Executive , American Society , Hematology Annual ,